soprobec 250 mikrogram/dosis inhalationsspray, opløsning
glenmark arzneimittel gmbh - beclometasondipropionat - inhalationsspray, opløsning - 250 mikrogram/dosis
trydonis
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - vedligeholdelsesbehandling hos voksne patienter med moderat til svær kronisk obstruktiv lungesygdom (kol), der ikke er tilstrækkeligt behandlet ved en kombination af et inhaleret binyrebarkhormon og en langtidsvirkende beta2-agonist (for effekter på symptomer kontrol og forebyggelse af eksacerbationer se afsnit 5.
riarify (previously chf 5993 chiesi farmaceutici s.p.a.)
chiesi farmaceutici s.p.a. - formoterol fumarate dihydrate, glycopyrronium, beclometasone dipropionate - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - vedligeholdelsesbehandling hos voksne patienter med moderat til svær kronisk obstruktiv lungesygdom (kol), der ikke er tilstrækkeligt behandlet ved en kombination af et inhaleret binyrebarkhormon og en langtidsvirkende beta2-agonist (for effekter på symptomer kontrol og forebyggelse af eksacerbationer se afsnit 5.
trimbow
chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarate dihydrat, glycopyrronium bromid - pulmonal sygdom, kronisk obstruktiv - medicin for obstruktiv sygdomme, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.
giona easyhaler 100 mikrogram/dosis inhalationspulver
2care4 aps - budesonid - inhalationspulver - 100 mikrogram/dosis
giona easyhaler 100 mikrogram/dosis inhalationspulver
orion corporation - budesonid - inhalationspulver - 100 mikrogram/dosis
giona easyhaler 200 mikrogram/dosis inhalationspulver
orifarm a/s - budesonid - inhalationspulver - 200 mikrogram/dosis
novopulmon novolizer 400 mikrogram inhalationspulver
mylan denmark aps - budesonid - inhalationspulver - 400 mikrogram
salmex 50+250 mikrog/dosis inhalationspulver, afdelt
glenmark pharmaceuticals nordic ab - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+250 mikrog/dosis
salmex 50+500 mikrog/dosis inhalationspulver, afdelt
glenmark pharmaceuticals nordic ab - fluticasonpropionat, salmeterolxinafoat - inhalationspulver, afdelt - 50+500 mikrog/dosis